Ethics and the Business of Bioscience

Portada
Stanford University Press, 2004 - 534 páginas
Businesses that produce bioscience products gene tests and therapies, pharmaceuticals, vaccines, and medical devices are regularly confronted with ethical issues concerning these technologies. Conflicts exist between those who support advancements in bioscience and those who fear the consequences of unfettered scientific license. As the debate surrounding bioscience grows, it will be increasingly important for business managers to consider the larger consequences of their work.

This groundbreaking book follows industry research, development, and marketing of medical and bioscience products across a variety of fields, including biotechnology, pharmaceuticals, and bio-agriculture. Compelling and current case studies highlight the ethical decisions business managers frequently face. With the increasing visibility and public expectation placed on businesses in this sector, managers need to understand the ethical and social issues. This book addresses that need and provides a framework for incorporating ethical analysis in business decision making.

 

Comentarios de la gente - Escribir un comentario

No encontramos ningún comentario en los lugares habituales.

Contenido

Acknowledgments
9
Research Ethics
9
Why study bioscience business ethics? 5
9
Benefits of addressing ethical and social issues
13
Ethics and Business Activity
23
Moral systems
31
Kantian ethics rights and duties
39
Justice and fairness
46
IndustrySponsored Clinical Research and the Use of Placebo Controls
195
Changing views on placebo controls
202
8
227
Mitigation of Harm to Subjects Injured in Clinical Research
235
Industry research practice
242
Conducting Clinical Research in Developing Countries
276
HIV transmission trial in Uganda
282
VaxGen Inc fighting the AIDS epidemic
288

Compensatory justice
55
Ethics Analysis Applied to Monsanto and the Labeling of rbST
70
Analysis of case study
84
Rights analysis
94
Ethical reasoning conclusions
101
Human research
106
Animal research
119
Industry Regulation and the Product Approval Process
129
Clinical trials process
137
Medical device regulation
143
Research Collaborations Between Academia and Industry
151
Changes in industryacademic relationships
159
Myriad and OncorMed and the marketing of
337
II
374
Compassionate use treatment INDs and parallel
380
Pharmaceutical companies and drug pricing
386
12
414
Advertising Prescription Drugs Directly to Patients
427
DTC prescription drug advertising expenditures
434
Zenecas directtoconsumer advertising
443
Geron Corporation and the role of ethics advice
490
Index
519
Derechos de autor

Otras ediciones - Ver todas

Términos y frases comunes

Referencias a este libro

The Biology of Cancer
Janice Ann Gabriel
Vista previa limitada - 2007

Acerca del autor (2004)

Margaret L. Eaton is a Senior Research Scholar at the Stanford Center for Biomedical Ethics and a Lecturer in the Stanford Graduate School of Business. She is a founding member of the Bioscience Business Ethics Center, Keck Graduate Institute, Claremont Colleges.

Información bibliográfica